|
|
News Breaks | | | | December 21, 2012 | | 07:46 EDT |  | MDRX | Allscripts price target lowered to $11 from $16 at RW Baird
Baird lowered its price target on Allscripts following its announcement management has concluded its exploration of strategic alternatives that did not produce a sale or merger of the company. The firm removed the takeout premium and believes investors should view the company as a long term investment with a conservative valuation. Shares remain Outperform rated. | |
|
News For MDRX From The Last 14 Days Check below for free stories on MDRX the last two weeks. |
|
|
| May 23, 2013 | | 09:39 EDT |  | MDRX | Allscripts downgraded to Outperform from Strong Buy at Raymond James
 Subscribe for More Information | | | May 14, 2013 | | 10:01 EDT |  | MDRX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | | 05:36 EDT | | MDRX | Allscripts upgraded to Buy from Neutral at Citigroup
Subscribe for More Information | | | May 9, 2013 | | 18:52 EDT |  | MDRX | On The Fly: After Hours Movers
UP AFTER EARNINGS: Ubiquiti Networks (UBNT), up 11.6%... Unilife (UNIS), up 10.8%... Sequenom (SQNM), up 9.8%. DOWN AFTER EARNINGS: priceline.com (PCLN), down 3.2%... Allscripts (MDRX), down 6.1%... Air Lease (AL), down 10%. ALSO LOWER: Affymax (AFFY), down 11% after disclosing in a regulatory filing that its financial position may prevent it from continuing operations... Discovery Labs (DSCO), down 8.5% after filing to sell common stock... magicJack (CALL), down 6.4% after naming a new CFO. | | | 16:08 EDT |  | MDRX | Allscripts reports Q1 EPS 9c, consensus 14c
Subscribe for More Information | |
|
|
|
|
|
|
